César Erazo/X
Nov 14, 2026, 13:45
César Erazo: Investigating Anticoagulation in Secondary Stroke Prevention at AHA 2026
César Erazo, Postgraduate of Internal Medicine at Cleveland Clinic, shared a post on X:
“Grateful to have attended AHA 2026 and presented our research on anticoagulation for secondary stroke prevention in patients with LVD!
Always inspiring to be surrounded by incredible minds in cardiovascular medicine.
Thankful to my residency program and mentors for their support!”
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 13:41Hussein Abdelwahab: FDA Approves Asundexian as the First Factor XIa Inhibitor for Stroke Prevention
-
Nov 14, 2026, 13:31John Augoustides: Practical Anticoagulation Strategies for Cardiopulmonary Bypass in Patients with HIT
-
Nov 14, 2026, 13:09Antonio Galante: Management of Portal Vein Thrombosis
-
Nov 14, 2026, 12:47Yasmin Mohtasham Kia: Anticoagulation Knowledge and Treatment Outcomes in Patients With Mechanical Heart Valves
-
Nov 14, 2026, 12:37Nathan Connell: Annualized Bleeding Rate and the Future of Hemophilia A Treatment
-
Nov 14, 2026, 12:3210 Posts Not to Miss This Week
-
Nov 14, 2026, 11:28Kalyan Roy: A New Era in Thalassemia Treatment – FDA Approves Mitapivat
-
Nov 14, 2026, 11:24Can Iron Deficiency Really be Seen in Someone’s Face? – ASH
-
Nov 14, 2026, 11:19Lindsay Davison: Putting Childhood Anemia in the Spotlight with IronUp and Danone